GlassScriptPhysician profile
Bartolomeo Giannattasio
NPI 1174552251
$7,984.94
in general payments reported to CMS, 2019-2025
23 companies · $303 in 2025
The $303 reported for 2025 was less than what a typical Clinical Cardiac Electrophysiology provider received nationally (typical 2025 total: $2,477).
See the full distribution for Clinical Cardiac Electrophysiology
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $92.63 · 2020: $2,333 · 2021: $6.72 · 2022: $2,240 · 2023: $2,623 · 2024: $386 · 2025: $303.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $2,275 · Food and Beverage: $1,037.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $2,275.00 |
| Food and Beverage | $1,037.26 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $4,452.73 | 2022-2025 | V-Loc 180, Pulseselect, Arctic Front Advance |
| Medtronic Vascular, INC. | $2,167.37 | 2020 | |
| Novartis Pharmaceuticals Corporation | $231.01 | 2019-2025 | |
| Atricure, INC. | $193.67 | 2023-2025 | Synergy Ablation System |
| Boston Scientific Corporation | $180.62 | 2020-2025 | Vigilant X4 Crt-D, Watchman Flx |
| E.R. Squibb & Sons, L.L.C. | $152.65 | 2023-2025 | Eliquis, Camzyos |
| Janssen Pharmaceuticals, INC | $112.15 | 2019-2024 | Xarelto |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $65.29 | 2019-2022 | |
| Pfizer INC. | $65.09 | 2020-2025 | |
| Abiomed | $60.00 | 2020 | |
| Merck Sharp & Dohme LLC | $53.34 | 2023 | Verquvo |
| Amgen INC. | $50.48 | 2019-2024 | Repatha |
| Boehringer Ingelheim Pharmaceuticals, INC. | $35.25 | 2023-2024 | Jardiance |
| Bridgebio Pharma, INC. | $31.52 | 2025 | Attruby |
| Terumo Medical Corporation | $20.05 | 2019 |
Show all 23 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Kestra Medical Technology Services, INC. | $18.73 | 2025 | Assure Wcd |
| Philips North America LLC | $17.38 | 2025 | Ecc Solutions |
| Daiichi Sankyo INC. | $16.49 | 2023 | Injectafer |
| Actelion Pharmaceuticals US, INC. | $15.66 | 2024 | Opsumit |
| Astrazeneca Pharmaceuticals LP | $15.00 | 2020 | |
| Sanofi-Aventis U.S. LLC | $12.37 | 2022 | |
| Irhythm Technologies, INC. | $11.37 | 2020 | |
| United Therapeutics Corporation | $6.72 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Bartolomeo Giannattasio listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.